Article
Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization.
Cancer medicine - 1 Jan 2024
Mendoza Rachelle P, Chen-Yost Heather I-Hsuan, Wanjari Pankhuri, Wang Peng, Symes Emily, Johnson Daniel N, Reeves Ward, Mueller Jeffrey, Antic Tatjana, Biernacka Anna
Abstract excerpt
BACKGROUND: TP53 mutation is present in about 50.8% of lung adenocarcinomas, frequently in combination with other genetic alterations. However, a rare subset harbors the TP53 mutation alone. METHODS: Next-generation sequencing was performed in 844 lung adenocarcinomas diagnosed by fine needle aspiration. Fourteen cases (1.7%) showed isolated TP53 alteration and were subjected to a comprehensive analysis. RESULTS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
